Table 2.
Receipt of Breast Conserving Surgery by SSDI Status and Disability Group
|
Disability Group* |
|||||
|---|---|---|---|---|---|
| Population by Tumor Stage | Not SSDI | Mental Disorders | Neurological Conditions | Circulatory/ Respiratory | Musculoskeletal |
| Percent with breast conserving surgery† | |||||
| All women | 51.5 | 43.8 | 41.9 | 46.4 | 53.0 |
| Stage I | 62.2 | 54.3 | 53.2 | 55.6 | 63.5 |
| Stage IIA | 46.0 | 35.9 | 33.3 | 39.6 | 42.1 |
| Stage IIB | 29.5 | 29.4 | 25.0 | 26.1 | 29.3 |
| Adjusted relative risk (95% CI)‡ | |||||
| All women | 1.00 | 0.80 (0.74, 0.87) | 0.77 (0.66, 0.91) | 0.87 (0.77, 0.98) | 0.95 (0.88, 1.03) |
| Stage I | 1.00 | 0.80 (0.73, 0.88) | 0.81 (0.66, 0.98) | 0.88 (0.77, 1.00) | 0.96 (0.88, 1.05) |
| Stage IIA | 1.00 | 0.75 (0.63, 0.89) | 0.68 (0.47, 0.99) | 0.83 (0.64, 1.06) | 0.93 (0.78, 1.10) |
| Stage IIB | 1.00 | 0.91 (0.71, 1.17) | 0.83 (0.47, 1.45) | 0.95 (0.61, 1.50) | 0.96 (0.65, 1.42) |
See Table 1 for definition of disability groups.
Other women received mastectomy.
Adjusted for: age at diagnosis (continuous), race/ethnicity, marital status, tumor registry, year of diagnosis, stage at diagnosis (only the model of all women combined), tumor size (continuous), histology, grade, estrogen receptor status, and progesterone receptor status.